BetterLife Pharma Inc. BETRF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.49M | -444.40K | -274.40K | -294.80K | -359.90K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 869.10K | 147.30K | -69.80K | 40.50K | -54.70K |
| Change in Net Operating Assets | -381.60K | 122.60K | 36.30K | 245.70K | 289.20K |
| Cash from Operations | -1.01M | -174.50K | -308.00K | -8.60K | -125.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 2.00M | -- | 386.00K | 0.00 | 25.00K |
| Total Debt Repaid | -3.30K | -3.20K | -3.20K | -1.80K | -- |
| Issuance of Common Stock | 352.50K | 258.30K | 48.20K | 0.00 | 150.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -- | -- | -- | -- |
| Cash from Financing | 1.68M | 186.00K | 310.80K | -1.30K | 127.40K |
| Foreign Exchange rate Adjustments | 0.00 | 100.00 | 400.00 | -400.00 | 300.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 676.90K | 11.70K | 3.30K | -10.20K | 2.30K |